Microbiome sequencing options are the methods used to characterize the microbes living in the gut and other body sites. This article explains the most common sequencing approaches, what each method measures, how they compare, and how to choose the right option for your research or health goals. You’ll learn about 16S rRNA sequencing, ITS sequencing, shotgun metagenomics, whole‑genome sequencing, metatranscriptomics, and how nanopore compares to Illumina platforms. This guide is informational—not a clinical diagnosis—and helps you move from general awareness toward informed discussions with providers or researchers.

What Are the Main Types of Microbiome Sequencing?

Microbiome sequencing methods fall into several categories, each targeting different genetic material and providing different levels of detail. The most commonly used are 16S rRNA amplicon sequencing, ITS sequencing, shotgun metagenomics, whole‑genome sequencing, and metatranscriptomics. Here’s a closer look at each.

16S rRNA Gene Sequencing

What it measures: 16S rRNA sequencing targets a conserved bacterial gene (16S ribosomal RNA) to identify bacterial taxa, typically resolving to the genus level and sometimes to species with limitations.

Typical uses: Broad community profiling, diversity and richness metrics, screening for overall shifts between groups or over time, and budget‑sensitive studies.

Strengths and limitations: 16S is cost‑effective and well‑established for bacterial community surveys. It provides reliable patterns of relative abundance and alpha/beta diversity but offers limited resolution for strain‑level differences and minimal direct functional information. It does not capture viruses, fungi, or host DNA reliably.

ITS Sequencing (for Fungi)

What it measures: ITS (Internal Transcribed Spacer) sequencing targets the region between ribosomal RNA genes in fungi, enabling identification of fungal species and genera.

Typical uses: Fungal community profiling in samples where yeast or mold overgrowth is suspected, often used alongside 16S for a complete picture of the microbiome.

Strengths and limitations: ITS sequencing is a dedicated method for fungal detection, but it does not provide information on bacteria or viruses. It is more expensive than 16S when used as an add‑on and requires specific primers and reference databases.

Shotgun Metagenomics

What it measures: Shotgun metagenomics sequences all DNA in the sample, enabling species‑ and sometimes strain‑level taxonomic resolution, detection of bacteria, archaea, viruses, and fungi (to varying degrees), and inference of functional genes and metabolic pathways.

Strengths and limitations: Shotgun provides a comprehensive, high‑resolution view and allows prediction of functional potential (e.g., genes for carbohydrate metabolism, bile acid modification). It is more expensive, generates large datasets that require sophisticated bioinformatics, and may still need complementary approaches to confirm activity (RNA/metabolites). Interpretation can be complex and dependent on reference databases.

Whole‑Genome Sequencing (Isolate Sequencing)

What it measures: Whole‑genome sequencing (WGS) sequences the complete genome of a single cultured microbe, providing the highest resolution of genetic information, including strain‑level variations, antibiotic resistance genes, and virulence factors.

Typical uses: WGS is used in research and clinical settings when a specific pathogen needs to be characterized in detail, such as tracking outbreaks or studying resistance mechanisms. It requires prior culturing of the organism.

Strengths and limitations: WGS offers the most detailed genomic information but is limited to culturable microbes, which excludes many gut bacteria. It is more expensive and time‑consuming than other methods and is not suitable for broad community profiling.

Metatranscriptomics (RNA Sequencing)

What it measures: Metatranscriptomics sequences microbial RNA to capture active gene expression, revealing which genes are being transcribed at the time of sampling. This provides insight into what microbes are actually doing, rather than what they are capable of doing based on DNA alone.

Typical uses: Studies of microbial activity in response to diet changes, medications, or disease states. It is also used to assess functional dynamics in longitudinal studies.

Strengths and limitations: Metatranscriptomics provides a functional snapshot of microbial activity, but RNA is more fragile than DNA, requiring careful sample handling and rapid processing. It is more expensive and computationally intensive than DNA‑based methods.

How Do These Sequencing Methods Compare?

Choosing between sequencing methods involves weighing several factors. The table below summarizes the key differences across the main approaches.

Targets measured: 16S targets bacterial 16S rRNA gene; ITS targets fungal ITS region; shotgun targets all DNA; whole‑genome targets a single isolate’s genome; metatranscriptomics targets RNA.

Taxonomic resolution: 16S resolves to genus (sometimes species); ITS resolves to genus/species for fungi; shotgun resolves to species/strain; whole‑genome resolves to strain; metatranscriptomics resolves to species/strain depending on reference databases.

Functional insight: 16S limited; none for ITS; shotgun high (gene prediction); whole‑genome highest; metatranscriptomics high (actual expression).

Cost per sample: 16S low; ITS moderate; shotgun high; whole‑genome high; metatranscriptomics high.

Sample requirements: All require good‑quality DNA/RNA; RNA requires immediate stabilization. 16S, ITS, shotgun work with stool; whole‑genome requires culture isolate.

Speed: 16S and ITS fastest (1‑2 weeks); shotgun and whole‑genome 2‑4 weeks; metatranscriptomics 2‑4 weeks.

Strengths: 16S – cost‑effective for bacterial surveys; ITS – detects fungi; shotgun – comprehensive; whole‑genome – highest detail; metatranscriptomics – captures activity.

Limitations: 16S – no functional info, misses non‑bacteria; ITS – only fungi; shotgun – expensive, complex interpretation; whole‑genome – requires culture; metatranscriptomics – fragile RNA, higher cost.

Sequencing vs. Other Methods for Studying the Microbiome

Sequencing is not the only way to study microbes. Other methods include culturing, microscopy, quantitative PCR (qPCR), and metabolomics. Each has its own strengths and limitations.

Culturing: Growing microbes in the lab allows isolation of live organisms for antibiotic susceptibility testing and exact identification, but many gut bacteria are difficult to culture. Microscopy: Direct visualisation of microbes can reveal morphology and abundance, but it cannot identify species or function. qPCR: Targeted detection and quantification of specific organisms or genes using primers; it is fast and sensitive but limited to known targets. Metabolomics: Measures small molecules (short‑chain fatty acids, bile acids) produced by microbes, providing a functional readout of microbial activity. Combining sequencing with one or more of these methods often yields the most clinically relevant picture.

Which Sequencing Method Should You Choose?

The choice depends on your question. Here’s a simple decision guide:

• If you need a broad, low‑cost bacterial community survey and are interested in diversity and relative abundance, 16S sequencing is a good starting point.
• If you suspect fungal overgrowth or need to profile fungi alongside bacteria, add ITS sequencing.
• If you require species‑ or strain‑level resolution, detection of non‑bacterial organisms, or functional gene predictions, choose shotgun metagenomics.
• If you need to characterize a specific cultured pathogen in detail, whole‑genome sequencing is the best option.
• If you want to know what microbes are actively doing (not just their potential), metatranscriptomics provides a functional snapshot.

No single method is universally best. The right choice balances your research or clinical question, budget, and the depth of insight needed. Always discuss with a knowledgeable provider or clinician to ensure the method aligns with your goals.

Nanopore vs. Illumina: What’s the Difference?

Two major sequencing platforms are used in microbiome studies: Illumina and nanopore (e.g., Oxford Nanopore Technologies). They differ in read length, accuracy, turnaround time, portability, and typical use cases.

Read length: Illumina produces short reads (typically 150–300 base pairs), which are highly accurate but make assembling complex genomic regions difficult. Nanopore generates long reads (up to hundreds of thousands of base pairs), which can span repetitive regions and improve genome assembly, but with lower per‑base accuracy.

Accuracy: Illumina has very high per‑base accuracy (99.9%+), making it the gold standard for many applications. Nanopore accuracy has improved (now often >99% with newer chemistries and basecalling), but it is still slightly lower than Illumina for short reads. However, long reads can improve overall accuracy in complex regions.

Turnaround time: Illumina sequencing typically takes 1–3 days for library preparation and sequencing, plus bioinformatics. Nanopore offers real‑time sequencing, meaning data can be analyzed as it is generated, allowing faster turnaround for some applications.

Portability: Nanopore devices are small and portable (e.g., MinION fits in a pocket), enabling field‑based sequencing. Illumina instruments are larger and require a lab setting.

Typical use cases: Illumina is widely used for 16S amplicon sequencing and shotgun metagenomics where high accuracy is critical. Nanopore is valuable for rapid pathogen identification, long‑read assembly, and portable sequencing in remote settings.

The choice between them depends on whether you need ultra‑high accuracy (Illumina) or long reads and portability (Nanopore). Many labs use both platforms complementarily.

The Basic Workflow of Microbiome Sequencing

Regardless of the method, microbiome sequencing follows a general workflow:

1. Sample collection: Stool is the most common sample for gut microbiome studies. Collect according to provider instructions, avoiding recent antibiotics and recording diet and medications. Proper storage and prompt shipment are critical to preserve genetic material.
2. DNA or RNA extraction: The sample is processed to extract nucleic acids. For RNA‑based methods, immediate stabilization is required to prevent degradation.
3. Library preparation: The genetic material is prepared for sequencing. This may involve amplifying specific regions (16S, ITS) or fragmenting all DNA/RNA and adding adapters (shotgun, metatranscriptomics).
4. Sequencing: The library is loaded onto a sequencing platform (e.g., Illumina, Nanopore), which reads the genetic material and generates raw data (reads).
5. Bioinformatics analysis: Raw reads are processed using specialized software to remove low‑quality data, align to reference databases, and produce taxonomic and functional profiles. This step requires expertise and can vary between providers.
6. Interpretation: The results are interpreted in the context of the research question or clinical symptoms. A single snapshot is a starting point; longitudinal sampling and integration with other data provide deeper insight.

Important Limitations to Keep in Mind

All sequencing methods have limitations that affect the reliability and interpretation of results. Key considerations include:

• Contamination: Sample collection, lab reagents, and cross‑contamination can introduce foreign DNA, leading to false positives. Proper controls and sterile techniques are essential.
• Primer bias: In amplicon‑based methods (16S, ITS), the choice of primers can favor or exclude certain taxa, skewing the observed community composition.
• Reference database quality: Taxonomic assignment depends on the completeness and accuracy of reference databases. Many microbes remain uncharacterized, leading to “unknown” classifications.
• Relative abundance interpretation: Sequencing data typically report proportions of microbes, not absolute numbers. A change in one taxon’s relative abundance can be due to shifts in others, not a real change in its population.
• Batch effects: Variations in sample processing, sequencing runs, and lab protocols can introduce systematic differences that complicate comparisons across studies or time points.
• Single‑snapshot limitation: A one‑time test captures only a moment in time. The microbiome can fluctuate daily, so repeated sampling may be needed to distinguish transient changes from stable patterns.

Frequently Asked Questions About Microbiome Sequencing

1. What are the different types of microbiome sequencing? The main types are 16S rRNA amplicon sequencing, ITS sequencing, shotgun metagenomics, whole‑genome sequencing, and metatranscriptomics. Each targets different genetic material and provides different levels of taxonomic and functional detail.
2. What are the methods used to study the microbiome? Besides sequencing, methods include culturing, microscopy, quantitative PCR (qPCR), and metabolomics. Sequencing is the most comprehensive for identifying microbes and their functional potential, while other methods offer complementary strengths (e.g., culturing for live organisms, metabolomics for functional molecules).
3. Why is nanopore better than Illumina? Nanopore is better for applications requiring long reads (e.g., assembling repetitive regions), portability (field sequencing), and real‑time data analysis. Illumina has higher per‑base accuracy and is better for short‑read applications like 16S sequencing and high‑accuracy shotgun metagenomics. The choice depends on the specific needs of the study.

Key Takeaways

• 16S sequencing is cost‑effective for broad bacterial surveys; shotgun metagenomics gives deeper taxonomic and functional detail.
• ITS sequencing targets fungi, whole‑genome sequencing is for isolated microbes, and metatranscriptomics captures active gene expression.
• Choice of method should align with your research or clinical question, budget, and desired resolution.
• Nanopore and Illumina platforms have different strengths—accuracy vs. long reads and portability.
• A single snapshot has limits; longitudinal testing helps distinguish transient changes from stable patterns.
• Interpret results alongside clinical context, symptoms, and other lab tests. Sequencing is a tool for awareness and monitoring, not a standalone diagnosis.

For those interested in testing, review provider methodology, ask which sequencing method they use, and consider how results will guide your next steps. If you’re exploring repeated measures, a gut microbiome test subscription and longitudinal testing may help track changes over time. For clinics and labs, see the B2B gut microbiome platform for integration options.